Company / EPS (Diluted)
Edesa Biotech, Inc. EPS (Diluted) History
FY2014-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$0.74
FY2021
5-year range
-$3.44 / -$0.36
FY2017-FY2021
Trend
-34.5%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) has fluctuated over the past 7 years, ranging from $-3.44 in FY2018 to $-0.13 in FY2014.
Based on SEC 10-K filings.
-0.74 in FY2021.
Improved from $-3.44 to $-0.74 over the past 3 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, eps (diluted) decreased 34.5% year-over-year.
- Peak eps (diluted) was recorded in FY2014.
- Lowest eps (diluted) in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2021 | -$0.74 | -34.5% |
| FY2020 | -$0.55 | +84.0% |
| FY2018 | -$3.44 | -855.6% |
| FY2017 | -$0.36 | +67.6% |
| FY2016 | -$1.11 | +60.5% |
| FY2015 | -$2.81 | -2061.5% |
| FY2014 | -$0.13 | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026